Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.31 |
| ▸ | CDK1 | P06493 | 1/20 | 0.31 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.31 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27144006 | 0.83 | KDM4E (0.33) | KDM4EUSP2HPGDHSD17B10TSHR | |
| SCHEMBL27147361 | 0.82 | CCNB2 (0.31) | CCNB2CDK1CCNB1CCNB3 | |
| SCHEMBL27147095 | 0.78 | HTT (0.34) | CCNB2CDK1CCNB1CCNB3 | |
| SCHEMBL27143023 | 0.78 | KDM4E (0.40) | KDM4EUSP2HPGDHSD17B10TSHR | |
| SCHEMBL27144103 | 0.78 | CCNC (0.36) | KDM4EUSP2HPGDHSD17B10TSHR | |
| SCHEMBL27144131 | 0.76 | HCAR2 (0.36) | HPGDTSHRCCNB2CDK1CCNB1 | |
| SCHEMBL27150686 | 0.73 | KDM4E (0.33) | KDM4EUSP2HPGDHSD17B10TSHR | |
| SCHEMBL27152985 | 0.72 | KDM4E (0.33) | KDM4EUSP2HPGDHSD17B10TSHR | |
| SCHEMBL27140486 | 0.70 | SMPD3 (0.34) | CCNB2CDK1CCNB1CCNB3 | |
| SCHEMBL27151848 | 0.67 | TSHR (0.31) | TSHRCCNB2CDK1CCNB1CCNB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240208911-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2024-06-27 | — | — | US | disclosed |
| EP-4326783-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2024-02-28 | — | — | EP | disclosed |
| CN-117222675-A | polymerization inhibitor | 巴斯夫欧洲公司 | 2023-12-12 | — | — | CN | disclosed |
| WO-2022223336-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2022-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240208911-A1 | POLYMERIZATION INHIBITORS | CDK5, CABLES1, DPYD | KDM4E 1624/4885USP2 780/4885HPGD 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.